Unlock Rapid Weight Loss with Semaglutide – Effortless and Effective!

The Patientory Inc. weight loss telemedicine program is powered by the CareGLP™ platform by CareValidate Inc. CareGLP™ is a patient management platform that collaborates with independent physicians and practitioners providing services through the SOC2 and HIPAA Compliant Care360 platform. CareValidate Inc. does not directly offer medical or pharmacy services, and payment does not guarantee the prescription writing or dispensing process. Medical services are facilitated by independent providers and Patel Group PC. The information presented on this website is for informational purposes only and should not be considered a substitute for professional medical advice, diagnosis, or treatment. If you have questions or concerns about your health, please consult with your doctor.

Patientory Inc. CareGLP is designed to be more than a telehealth platform, but still simple for our clients. You can start treatment in three easy-steps.
1) Complete our eligibility quiz and have our providers may request lab work done to verify a medical need for treatment.
2) Speak to your new healthcare provider through a telehealth appointment.
3) If medically appropriate, receive your medication in the mail every 30-days, or 60-days, or 90-days from our mail order pharmacy provider (depending on your provider’s decision).
We want to enable you to form a long-term connection with your provider so that they can provide ongoing care for your specific condition. With that in mind, The Patientory Inc. weight loss program is designed for patients seeking long-term care.

Yes. Your medical data and order history can only be viewed by our medical team and prescribers. You can view our Privacy Policy for more information.

If you’re eligible for treatment, our medical team will issue you a private prescription. You don’t need an existing prescription to use the Patientory Inc. Weight loss program!

Patientory Inc’s CareGLP medical weight loss program will create a customized prescription plan just for you. Guided by doctors, you will receive a personalized plan, medication, and support. The monthly cost is $199, which includes Medical Telehealth Consultations with a licensed Health Care Provider, a monthly prescription of Weight Loss Medication (GLP1-s), and Shipping to your home.

Your shipment will arrive promptly after our doctors review your progress and issue the next prescription. Routinely every 30 days. You will always have medicine on hand to continue your journey.

Actual weight lost is dependent on a number of factors but many Patientory Inc. clients lose around 5% of their initial body weight. Over 12 weeks, it can be as high as 10%. This equates to a weight loss of 10–20 pounds for a 200 pound person

Please see our learning videos on GLP1 Injection How-to-Videos about performing a subcutaneous injection. Always ask your provider or licensed medical professional if you have any difficulties or questions.

When a drug is in shortage, compounders can prepare a compounded version of that drug if they meet certain requirements in the Federal Food, Drug, and Cosmetic (FD&C) Act.

You can check for drug shortages on the FDA website.

Pharmacies in the CareGLP network comply strictly with all the regulatory standards established by:

• State boards of pharmacy, which regulate all 503A pharmacies
• FDA, which has oversight for the safety of all active pharmaceutical ingredients
• DEA, that oversees the controlled substances sometimes used in compounded preparations
• USP Convention, that issues practice standards ensuring quality and safety of medications and food
• USP General Chapter <795> provides guidelines for the prevention of contamination and potency variance, preparation process, beyond-use dates, and stability for non-sterile compounding

Pharmacies in the CareGLP network run quality assurance and quality control checks for every batch of compounded semaglutide prescribed to patients.

Some of these steps include but are not limited to:

• Reviewing and confirming the Active Pharmaceutical Ingredient (API) Certificate of Analysis for all semaglutide base lots, which are received from FDA-registered manufacturers;
• Storing the verified API frozen and sealed until use;
• Compounding with the API under aseptic processes to produce specific lots (vials);
• Holding the vials of compounded semaglutide in quarantine (representative samples are taken for testing);
• Using independent third-party laboratories to test the potency, sterility and endotoxicity of each lot of compounded semaglutide (among other criteria);
• Reviewing the results of these tests and, if satisfactory, releasing the validated vials from quarantine for dispensing;
• Assigning each compounded lot a unique lot number and BUD (Beyond Use Date), which is added to the container and is tracked electronically;
• Scanning the lot information on the product at the time of dispensing, which ties a particular lot number to the patient’s file.

Notify your provider immediately if you notice a lump or swelling in your neck, hoarseness, difficulty swallowing, or shortness of breath. These could be symptoms of thyroid cancer.
Semaglutide is contraindicated if you or any of your family members have ever had medullary thyroid carcinoma (MTC), or if you suffer from an endocrine system condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
The safety and efficacy of combining semaglutide with other weight loss products have not been established.
Sharing your complete medical history with your provider is crucial. Specifically, inform your provider if you have a history of:
Type 1 or Type 2 diabetes,
Thyroid cancer,
Pancreatitis,
Kidney disease,
Diabetic retinopathy,
Depression,
Suicidal thoughts or behavior